136.20

4.06% -5.76

Transmedics Group Inc (TMDX)

Overview News Price History Option Chain Financials Why TMDX Down? Discussions Forecast

Transmedics Group Inc stock is traded at $136.20, with a volume of 902.32K. It is down -4.06% in the last 24 hours and up +12.03% over the past month. TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Previous Close:

$141.96

Open:

$140.15

24h Volume:

902.32K

Relative Volume:

0.88

Market Cap:

$4.77B

Revenue:

$401.09M

Net Income/Loss:

$32.64M

P/E Ratio:

144.89

EPS:

0.94

Net Cash Flow:

$-120.51M

1W Performance:

-3.31%

1M Performance:

+12.03%

6M Performance:

+107.29%

1Y Performance:

-4.81%

1-Day Range:

$136.05

$141.90

1-Week Range:

$136.05

$145.50

52-Week Range:

$55.00

$177.37

Transmedics Group Inc Stock (TMDX) Company Profile

Name

Transmedics Group Inc

Sector

Healthcare (1172)

Industry

Medical Devices (150)

Phone

(978) 552-0900

Address

200 MINUTEMAN ROAD, ANDOVER, MA

Employee

728

Twitter

@transmedics

Next Earnings Date

2024-10-28

Latest SEC Filings

TMDX's Discussions on Twitter

Compare TMDX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TMDX Transmedics Group Inc	136.20	4.77B	401.09M	32.64M	-120.51M	0.94
ABT Abbott Laboratories	132.28	233.36B	42.34B	13.50B	6.66B	7.71
SYK Stryker Corp	373.37	147.15B	23.22B	2.86B	3.58B	7.40
BSX Boston Scientific Corp	101.73	146.97B	17.55B	2.03B	2.72B	1.37
MDT Medtronic Plc	86.17	112.76B	33.54B	4.66B	5.19B	3.62
EW Edwards Lifesciences Corp	73.27	44.46B	5.54B	4.18B	623.10M	7.00

Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-17-24	Downgrade	JP Morgan	Overweight → Neutral
Nov-22-24	Downgrade	Needham	Buy → Hold
Oct-29-24	Reiterated	Needham	Buy
Oct-29-24	Reiterated	Oppenheimer	Outperform
Sep-24-24	Initiated	Robert W. Baird	Outperform
Aug-21-24	Initiated	Needham	Buy
Jun-06-24	Initiated	Cantor Fitzgerald	Overweight
Jun-04-24	Initiated	Stephens	Overweight
Mar-28-24	Initiated	Piper Sandler	Overweight
Jul-19-23	Initiated	Robert W. Baird	Outperform
Aug-02-22	Upgrade	JP Morgan	Neutral → Overweight
Oct-08-20	Downgrade	JP Morgan	Overweight → Neutral
Apr-07-20	Initiated	Oppenheimer	Outperform
May-28-19	Initiated	Canaccord Genuity	Buy
May-28-19	Initiated	Cowen	Outperform
May-28-19	Initiated	JP Morgan	Overweight
May-28-19	Initiated	Morgan Stanley	Equal-Weight

View All

Transmedics Group Inc Stock (TMDX) Latest News

03:00 AM

TransMedics Group (NASDAQ:TMDX) Price Target Raised to $150.00 at Oppenheimer - Defense World

03:00 AM

Jun 17, 2025

TransMedics price target raised to $150 from $130 at Oppenheimer By Investing.com - Investing.com Canada

Jun 17, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Shareholders to Connect - ACCESS Newswire

Jun 17, 2025

(TMDX) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

Jun 17, 2025

Oppenheimer Adjusts Price Target for TransMedics (TMDX) to $150 - GuruFocus

Jun 17, 2025

Oppenheimer Hikes TransMedics Group Price Target to $150 From $130, Maintains Outperform Rating - marketscreener.com

Jun 17, 2025

TransMedics Group, Inc. (NASDAQ:TMDX) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World

Jun 17, 2025

Jun 16, 2025

Handelsbanken Fonder AB Sells 72,000 Shares of TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat

Jun 16, 2025

Jun 15, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against TransMedics Group, Inc. (TMDX) And Encourages Shareholders to Reach Out - ACCESS Newswire

Jun 15, 2025

Jun 13, 2025

Rhumbline Advisers Sells 537 Shares of TransMedics Group, Inc. (NASDAQ:TMDX) - Defense World

Jun 13, 2025

TransMedics Group, Inc. (NASDAQ:TMDX) Shares Bought by GAMMA Investing LLC - MarketBeat

Jun 13, 2025

Jun 12, 2025

TransMedics Group, Inc. (NASDAQ:TMDX) Insider Anil P. Ranganath Sells 686 Shares - MarketBeat

Jun 12, 2025

Mid-Cap Marvels: 3 Stocks That Crushed Sales Estimates in May - MarketBeat

Jun 12, 2025

Two Sigma Investments LP Purchases Shares of 12,523 TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat

Jun 12, 2025

Jun 10, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against TransMedics Group, Inc. (TMDX) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire

Jun 10, 2025

Jun 09, 2025

TransMedics at Goldman Sachs Conference: Strategic Growth and Challenges By Investing.com - Investing.com Nigeria

Jun 09, 2025

TransMedics at Goldman Sachs Conference: Strategic Growth and Challenges - Investing.com

Jun 09, 2025